Johnson & Johnson : le vaccin COVID-19 à injection unique est efficace à 66%

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceutical, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 37 on the 2018 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies.
85% is the vaccine's efficacy rate according to the results of a global trial
The company announced today that the Johnson and Johnson COVID-19 vaccine can prevent 85% of severe cases of the disease,
now fully recruited with around 45,000 participants 

Post a Comment

Previous Post Next Post